NanOlogy Press Releases
NanOlogy Press Releases
-
NanOlogy Announces Two Abstracts Have Been Accepted for Presentation at AACR Special Conference in Cancer Research: Pancreatic Cancer
September 12, 2023 by NanOlogy
-
NanOlogy Presents Clinical Research at 2023 DDW and ASCO Involving its Large Surface Area Microparticle Investigational Drugs
June 7, 2023 by NanOlogy
-
NanOlogy Granted a US Patent for Its Investigational Drugs in Combination with Immune Checkpoint Inhibitors in the Treatment of Cancer
March 7, 2023 by NanOlogy
-
NanOlogy Publishes Results From a Clinical Trial of Intracystic LSAM-PTX in Mucinous Pancreatic Cysts
December 20, 2022 by NanOlogy
-
NanOlogy Completes Enrollment in Phase 2a Trial of Intratumoral LSAM-PTX with SOC in Patients with Nonoperable Lung Cancer
November 11, 2022 by NanOlogy
-
NanOlogy Publishes Review Article of Preclinical and Clinical Research Supporting LSAM-DTX
September 20, 2022 by NanOlogy
-
NanOlogy Publishes Results from a Phase 1/2 Clinical Trial of Large Surface Area Microparticle Docetaxel in High-Risk Non-Muscle Invasive Bladder Cancer
August 1, 2022 by NanOlogy
-
NanOlogy Publishes Results from a Phase 1/2 Clinical Trial of its Topical Investigational Drug in the Treatment of Cutaneous Metastases of Breast Cancer
May 3, 2022 by NanOlogy
-
Improved Resection Rates in Locally Advanced Pancreatic Cancer Following Addition of Intratumoral NanoPac® to Standard of Care
November 9, 2021 by NanOlogy
-
Additional Data Presented at DDW® 2021 from a Phase 2 Clinical Trial of Intracystic NanoPac® for Mucinous Cystic Neoplasms of the Pancreas
June 9, 2021 by NanOlogy
-
NanOlogy Announces First Patient Enrollment in Lung Cancer Clinical Trial
April 26, 2021 by NanOlogy
-
NanOlogy Completes Enrollment of Bladder Cancer Clinical Trial
March 9, 2021 by NanOlogy
-
NanOlogy Presents Results of SOR007 (Topical Submicron Particle Paclitaxel) Phase 1/2 Clinical Trial in the Treatment of Cutaneous Metastases at 2020 SABCS®
December 29, 2020 by NanOlogy
-
NanOlogy Enrolls First Patient in Phase 2 Clinical Trial of NanoPac® for Intratumoral Treatment of Prostate Cancer
November 4, 2020 by NanOlogy
-
NanOlogy Announces Initiation of a Lung Cancer Clinical Trial Following FDA Allowances of Two IND Applications for NanoPac® in Lung Cancer
June 9, 2020 by NanOlogy
-
NanOlogy Presents Updated Clinical Data on Targeted Injections of NanoPac® for Pancreatic Cancer and Mucinous Cystic Neoplasms on DDW2020 Site
May 14, 2020 by NanOlogy
-
NanOlogy Clinical Updates on Local Injection of NanoPac® for Pancreatic Cancer and Mucinous Cystic Neoplasms of the Pancreas
November 7, 2019 by NanOlogy
-
NanOlogy to Present Interim Data for Pancreatic Cancer and Mucinous Cystic Neoplasms of the Pancreas with Local Injection of NanoPac®
October 15, 2019 by NanOlogy
-
NanOlogy to Present Preclinical Lung Cancer Study Showing Inhaled NanoPac® Resulted in Increased Tumor Regression and Immune Response
May 14, 2019 by NanOlogy
-
NanOlogy announces First Patient Enrolled in a Phase 1/2 Clinical Trial of NanoDoce® for Treatment of Bladder Cancer
April 12, 2019 by NanOlogy
